Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3059 USD | +5.77% | +9.25% | -1.00% |
Sales 2024 * | 5.43M 452M | Sales 2025 * | 33.37M 2.78B | Capitalization | 30.77M 2.57B |
---|---|---|---|---|---|
Net income 2024 * | -29M -2.42B | Net income 2025 * | -7M -584M | EV / Sales 2024 * | 5.67 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.92 x |
P/E ratio 2024 * |
-1.13
x | P/E ratio 2025 * |
-5.1
x | Employees | 25 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.35% |
Latest transcript on Daré Bioscience, Inc.
1 day | +5.77% | ||
1 week | +9.25% | ||
Current month | -37.60% | ||
1 month | -44.28% | ||
3 months | -13.10% | ||
6 months | -27.51% | ||
Current year | -1.00% |
Managers | Title | Age | Since |
---|---|---|---|
Sabrina Johnson
FOU | Founder | 57 | 01/15/01 |
Annie Thurman
CTO | Chief Tech/Sci/R&D Officer | - | 01/22/01 |
Jessica Hatheway
CTO | Chief Tech/Sci/R&D Officer | - | 01/22/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robin Steele
BRD | Director/Board Member | 68 | 01/15/01 |
Cheryl Blanchard
BRD | Director/Board Member | 59 | 20/19/20 |
Chairman | 75 | 01/14/01 |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 0.3059 | +5.77% | 175,076 |
25/24/25 | 0.2892 | +1.12% | 325,527 |
24/24/24 | 0.286 | -3.80% | 436,098 |
23/24/23 | 0.2973 | +0.68% | 323,196 |
22/24/22 | 0.2953 | +5.46% | 165,190 |
Delayed Quote Nasdaq, April 27, 2024 at 01:30 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.00% | 30.77M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- DARE Stock